Sabine Swoboda

Sabine Swoboda

Auto-generated profile, based on publicly available information

Sabine Swoboda

Department of ORL, Head & Neck Surgery, Skåne University Hospital

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 October 2025 in Acta Oto-Laryngologica
Verified
Journal Article
Open access
SSSabine Swoboda
Sabine Swoboda
RVRobertas Vanagas
Robertas Vanagas
CACan Altunbulakli
Can Altunbulakli
DADavid Askmyr
David Askmyr
MLMalin Lindstedt
Malin Lindstedt
LGLennart Greiff
Lennart Greiff
Age-related immunosenescence, also known as 'inflammageing', may impact the elderly's ability to mount immune responses against cancers and compromise the effectiveness of immune checkpoint inhibition (ICI). In this context, data on tonsillar cancer (TC), a subset of head and neck squamous cell cancer (HNSCC), are lacking. To compare the presence/distribution and features of immune cells in TC, and of bulk RNA-seq in HNSCC, between the young and the elderly. TC tissue microarrays (TMAs) characterised by GeoMx digital spatial profiling were revisited and analysed, focusing on quantification and location of CD8+ and CD11c+ immune cells. De novo analyses of the TMAs targeted CD68+/CD163+ macrophages. Bulk RNA-seq and clinical data from patients with HNSCC were sourced from the Cancer Genome Atlas (TCGA). For all data, patients were stratified into age groups. Immune-cell characteristics in TC were similar across young and elderly individuals, although the elderly exhibited higher PD-1 levels. TCGA data revealed increased immune checkpoint molecules PD-L1 and LAG-3 in the elderly, alongside immunosuppression. In the elderly, key immune cells are present in TC, and immune checkpoint molecules are overexpressed. This may be relevant to the stratification of patients for ICI.